Ibritumomab tiuxetan (Zevalin) in non-Hodgkin's lymphoma clinical background, practical considerations, and case studies

Saved in:

Bibliographic Details
Corporate Author:	Clinical Oncology Advisory Board
Other Authors:	Cheson, Bruce D. 1946-
Format:	Book
Published:	New York, NY Oncology Group 2003
Subjects:	Radioimmunotherapy > methods Yttrium Radioisotopes > therapeutic use Lymphoma, Non-Hodgkin > therapy Antibodies, Monoclonal > therapeutic use
Online Access:	Click Here to View Status and Holdings.
Tags:	Add Tag No Tags, Be the first to tag this record!

MARC


LEADER	00000n a2200000 a 4501
001	wils-311676
020	#	#	\|a 1891483196
090	0	0	\|a WH525 \|b I14 2003
245	1	1	\|a Ibritumomab tiuxetan (Zevalin) in non-Hodgkin's lymphoma \|b clinical background, practical considerations, and case studies \|c edited by Bruce D. Cheson
260	#	#	\|a New York, NY \|b Oncology Group \|c 2003
300	#	#	\|a vi, 90 p. \|b ill \|c 18 cm
504	#	#	\|a Includes bibliographical references
650	#	0	\|a Radioimmunotherapy \|x methods
650	#	0	\|a Yttrium Radioisotopes \|x therapeutic use
650	#	0	\|a Lymphoma, Non-Hodgkin \|x therapy
650	#	0	\|a Antibodies, Monoclonal \|x therapeutic use
700	1	#	\|a Cheson, Bruce D. \|c 1946-
710	1	#	\|a Clinical Oncology Advisory Board
856	4	0	\|z Click Here to View Status and Holdings. \|u https://opac.uitm.edu.my/opac/detailsPage/detailsHome.jsp?tid=311676
964	#	#	\|c BOK \|d MD
040	#	#	\|a Shah Alam